Anbieter: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Deutschland
xv, 218 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 117,07
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 117,07
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Taschenbuch. Zustand: Neu. Critical Infrastructures: Risk and Vulnerability Assessment in Transportation of Dangerous Goods | Transportation by Road and Rail | Bogdan I. Vamanu (u. a.) | Taschenbuch | Topics in Safety, Risk, Reliability and Quality | xv | Englisch | 2018 | Springer | EAN 9783319809205 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 156,07
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 9.50x6.50x0.75 inches. In Stock.
Sprache: Englisch
Verlag: Springer International Publishing, Springer International Publishing, 2018
ISBN 10: 3319809202 ISBN 13: 9783319809205
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book addresses a key issue in today's society: the safer transport of dangerous goods, taking into account people, the environment and economics. In particular, it offers a potential approach to identifying the issues, developing the models, providing the methods and recommending the tools to address the risks and vulnerabilities involved. We believe this can only be achieved by assessing those risks in a comprehensive, quantifiable and integrated manner.Examining both rail and road transportation, the book is divided into three sections, covering: the mature and accepted (by both academia and practitioners) methodology of risk assessment; the vulnerability assessment - a novel approach proposed as a vital complement to risk; guidance and support to build the tools that make methods and equations to yield: the Decision Support Systems. Throughout the book, the authors do not endeavor to provide THE solution. Instead, the book offers insightful food for thought for students, researchers, practitioners and policymakers alike.
Sprache: Englisch
Verlag: Springer International Publishing, 2016
ISBN 10: 3319309293 ISBN 13: 9783319309293
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book addresses a key issue in today's society: the safer transport of dangerous goods, taking into account people, the environment and economics. In particular, it offers a potential approach to identifying the issues, developing the models, providing the methods and recommending the tools to address the risks and vulnerabilities involved. We believe this can only be achieved by assessing those risks in a comprehensive, quantifiable and integrated manner.Examining both rail and road transportation, the book is divided into three sections, covering: the mature and accepted (by both academia and practitioners) methodology of risk assessment; the vulnerability assessment - a novel approach proposed as a vital complement to risk; guidance and support to build the tools that make methods and equations to yield: the Decision Support Systems. Throughout the book, the authors do not endeavor to provide THE solution. Instead, the book offers insightful food for thought for students, researchers, practitioners and policymakers alike.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 193,33
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 475 pages. 9.25x6.10 inches. In Stock.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides an in-depth exploration of microbiota profiling and precision medicine, including the underlying mechanisms, delivery methods, treatment strategies, and the impact of biomarker-targeted drug delivery. It incorporates the latest research findings, such as biomarker-targeted drug delivery, clinical assessment and diagnosis, and therapeutic approaches. The book offers a comprehensive overview of the latest developments in biomarker-targeted drug delivery strategies. It addresses the challenges faced by healthcare professionals, offering actionable strategies for effective multidisciplinary care, along with patient and family perspectives, coping mechanisms, and ways to improve quality of life. By combining scientific knowledge, clinical expertise, and patient insights, the book enhances understanding, diagnosis, and treatment options for these complex conditions. These qualities distinguish it from existing publications and make it a valuable resource for readers seeking a thorough and engaging overview of this subject.The chapters cover a broad range of topics, including recent advances in microbiota profiling techniques, microbiota's role in drug metabolism and toxicity, and its immunomodulatory effects. Special focus is given to the involvement of microbiota in neurodegenerative diseases such as Alzheimer's and Parkinson's, emphasizing the therapeutic potential of microbiome-targeted strategies. The authors provide expert analysis on integrating microbiota-derived data with innovative tools like nanotechnology and machine learning to improve drug delivery systems. Readers will also gain practical insights from case studies on microbiota-informed therapies for cancer, autoimmune conditions, and gastrointestinal disorders. This book is essential for researchers, clinicians, academicians, and students working in microbiome science, pharmacology, biotechnology, and precision medicine. It addresses key questions such as biomarker validation, data integration, and the ethical considerations necessary for the clinical use of microbiome-based therapies.